Literature DB >> 13637598

Metabolic studies of chlorpropamide in normal men and in diabetic subjects.

R E KNAUFF, S S FAJANS, E RAMIREZ, J W CONN.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/metabolism

Mesh:

Substances:

Year:  1959        PMID: 13637598     DOI: 10.1111/j.1749-6632.1959.tb39585.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  13 in total

1.  GLYCODIAZINE IN DIABETES MELLITUS: A CLINICAL TRIAL.

Authors:  R D STEWART; D E ANDERSON
Journal:  Br Med J       Date:  1965-09-18

2.  Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.

Authors:  H S SELTZER
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

3.  Severe hypoglycemic reaction with chlorpropamide in therapeutic dosage.

Authors:  E B LEVIN
Journal:  Calif Med       Date:  1963-05

4.  Further experience with oral therapy in diabetes.

Authors:  K L GRANVILLE-GROSSMAN; S CRAWFURD; M F CROWLEY; A BLOOM
Journal:  Br Med J       Date:  1959-10-31

5.  THE EXPERIMENTAL INDUCTION IN MAN OF SENSITIVITY TO LEUCINE HYPOGLYCEMIA.

Authors:  S S Fajans; R F Knopf; J C Floyd; L Power; J W Conn
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

6.  Pharmacokinetics.

Authors:  R Müller
Journal:  Acta Diabetol Lat       Date:  1970 Jul-Aug

Review 7.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

8.  Bioavailability of chlorpropamide.

Authors:  M Evans; R C Glass; M Mitchard; B M Munday; R Yates
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

Review 9.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

10.  Clinical experience with chlorpro-pamide.

Authors:  G WALKER; L W KINSELL
Journal:  Calif Med       Date:  1961-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.